Avid Bioservices, Inc., a biologics CDMO, initiated the second phase of expansion of manufacturing capacity at its Myford facility. The build out of the Myford facility will include a second manufacturing train with both upstream and downstream processing suites, known as Myford South.    The company expects the Myford South build out to take 18 to 24 months to complete at a cost of approximately $45 million to $55 million. Upon completion, Avid estimates that the addition has the potential to...